KRAS c.468C>A ;(p.F156L)

Variant ID: 12-25362828-G-T

NM_004985.3(KRAS):c.468C>A;(p.F156L)

This variant was identified in 24 publications

View GRCh38 version.




Publications:


Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg.

Therapeutic Advances In Medical Oncology
Rosen, Joshua C JC; Sacher, Adrian A; Tsao, Ming-Sound MS
Publication Date: 2023

Variant appearance in text: KRAS: F156L
PubMed Link: 36950276
Variant Present in the following documents:
  • Main text
  • 10.1177_17588359231160141.pdf
View BVdb publication page



Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.

Nature Communications
Sivakumar, Smruthy S; Jin, Dexter X DX; Tukachinsky, Hanna H; Murugesan, Karthikeyan K; McGregor, Kimberly K; Danziger, Natalie N; Pavlick, Dean D; Gjoerup, Ole O; Ross, Jeffrey S JS; Harmon, Robert R; Chung, Jon J; Decker, Brennan B; Dennis, Lucas L; Frampton, Garrett M GM; Molinero, Luciana L; Oesterreich, Steffi S; Venstrom, Jeffrey M JM; Oxnard, Geoffrey R GR; Hegde, Priti S PS; Sokol, Ethan S ES
Publication Date: 2022-12-05

Variant appearance in text: KRAS: F156L
PubMed Link: 36470901
Variant Present in the following documents:
  • 41467_2022_35245_MOESM4_ESM.xlsx, sheet 17
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: KRAS: F156L
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.

Blood
Ansari-Pour, Naser N; Samur, Mehmet K MK; Flynt, Erin E; Gooding, Sarah S; Towfic, Fadi F; Stong, Nicholas N; Ortiz Estevez, Maria M; Mavrommatis, Konstantinos K; Walker, Brian A BA; Morgan, Gareth J GJ; Munshi, Nikhil C NC; Avet Loiseau, Herve H; Thakurta, Anjan A
Publication Date: 2022-10-12

Variant appearance in text: KRAS: F156L
PubMed Link: 36223594
Variant Present in the following documents:
  • BLOOD_BLD-2022-017010-mmc2.xlsx, sheet 1
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: KRAS: 468C>A; F156L
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response.

Cell Reports. Medicine
Weir, William H WH; Mucha, Peter J PJ; Kim, William Y WY
Publication Date: 2022-05-17

Variant appearance in text: KRAS: Phe156Leu
PubMed Link: 35584624
Variant Present in the following documents:
  • mmc2.xlsx, sheet 4
View BVdb publication page



Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.

Blood Advances
Tran, Thai Hoa TH; Langlois, Sylvie S; Meloche, Caroline C; Caron, Maxime M; Saint-Onge, Pascal P; Rouette, Alexandre A; Bataille, Alain R AR; Jimenez-Cortes, Camille C; Sontag, Thomas T; Bittencourt, Henrique H; Laverdière, Caroline C; Lavallée, Vincent-Philippe VP; Leclerc, Jean-Marie JM; Cole, Peter D PD; Gennarini, Lisa M LM; Kahn, Justine M JM; Kelly, Kara M KM; Michon, Bruno B; Santiago, Raoul R; Stevenson, Kristen E KE; Welch, Jennifer J G JJG; Schroeder, Kaitlin M KM; Koch, Victoria V; Cellot, Sonia S; Silverman, Lewis B LB; Sinnett, Daniel D
Publication Date: 2022-02-22

Variant appearance in text: KRAS: F156L
PubMed Link: 34933343
Variant Present in the following documents:
  • advancesADV2021005634-suppl1.xlsx, sheet 1
  • advancesADV2021005634-suppl1.xlsx, sheet 3
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: KRAS: F156L
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Embryonic Expression of NrasG 12 D Leads to Embryonic Lethality and Cardiac Defects.

Frontiers In Cell And Developmental Biology
You, Xiaona X; Ryu, Myung-Jeom MJ; Cho, Eunjin E; Sang, Yanzhi Y; Damnernsawad, Alisa A; Zhou, Yun Y; Liu, Yangang Y; Zhang, Jing J; Lee, Youngsook Y
Publication Date: 2021

Variant appearance in text: KRAS: F156L
PubMed Link: 33681212
Variant Present in the following documents:
  • Main text
  • fcell-09-633661.pdf
View BVdb publication page



Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies.

Clinical And Translational Medicine
Li, Ziyang Z; Huang, Wensou W; Yin, Jiani C JC; Na, Chenglong C; Wu, Xue X; Shao, Yang Y; Ding, Huaxin H; Li, Jinming J
Publication Date: 2020-11

Variant appearance in text: KRAS: F156L
PubMed Link: 33252848
Variant Present in the following documents:
  • Main text
  • CTM2-10-e222.pdf
View BVdb publication page



KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples.

Translational Lung Cancer Research
Loong, Herbert Ho-Fung HH; Du, Nan N; Cheng, Chunyan C; Lin, Hanqing H; Guo, Jian J; Lin, Gen G; Li, Mingjiang M; Jiang, Tao T; Shi, Zhihua Z; Cui, Yanzhi Y; Jin, Xianfeng X; Yao, Jicheng J; Xing, Yutong Y; Yao, Ming M; Wang, Kai K; Mok, Tony S K TSK; Liu, Lunxu L
Publication Date: 2020-10

Variant appearance in text: KRAS: F156L
PubMed Link: 33209599
Variant Present in the following documents:
  • Main text
  • tlcr-09-05-1759.pdf
View BVdb publication page



Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.

Journal For Immunotherapy Of Cancer
Hong, Tae Hee TH; Cha, Hongui H; Shim, Joon Ho JH; Lee, Boram B; Chung, Jongsuk J; Lee, Chung C; Kim, Nayoung K D NKD; Choi, Yoon-La YL; Hwang, Soohyun S; Lee, Yoomi Y; Park, Sehhoon S; Jung, Hyun Ae HA; Kim, Ji-Yeon JY; Park, Yeon Hee YH; Sun, Jong-Mu JM; Ahn, Jin Seok JS; Ahn, Myung-Ju MJ; Park, Keunchil K; Lee, Se-Hoon SH; Park, Woong-Yang WY
Publication Date: 2020-10

Variant appearance in text: KRAS: F156L
PubMed Link: 33077514
Variant Present in the following documents:
  • jitc-2020-001199supp002.pdf
View BVdb publication page



Identification of pathogenic missense mutations using protein stability predictors.

Scientific Reports
Gerasimavicius, Lukas L; Liu, Xin X; Marsh, Joseph A JA
Publication Date: 2020-09-21

Variant appearance in text: KRAS: F156L
PubMed Link: 32958805
Variant Present in the following documents:
  • 41598_2020_72404_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts.

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology
Dunnett-Kane, V V; Burkitt-Wright, E E; Blackhall, F H FH; Malliri, A A; Evans, D G DG; Lindsay, C R CR
Publication Date: 2020-07

Variant appearance in text: KRAS: F156L
PubMed Link: 32240795
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R.

Birth Defects Research
Bera, Asim K AK; Lu, Jia J; Lu, Chunya C; Li, Lianbo L; Gondi, Sudershan S; Yan, Wei W; Nelson, Andrew A; Zhang, Goujun G; Westover, Kenneth D KD
Publication Date: 2020-06

Variant appearance in text: KRAS: F156L
PubMed Link: 32187889
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: KRAS: F156L
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.

Blood
Li, Benshang B; Brady, Samuel W SW; Ma, Xiaotu X; Shen, Shuhong S; Zhang, Yingchi Y; Li, Yongjin Y; Szlachta, Karol K; Dong, Li L; Liu, Yu Y; Yang, Fan F; Wang, Ningling N; Flasch, Diane A DA; Myers, Matthew A MA; Mulder, Heather L HL; Ding, Lixia L; Liu, Yanling Y; Tian, Liqing L; Hagiwara, Kohei K; Xu, Ke K; Zhou, Xin X; Sioson, Edgar E; Wang, Tianyi T; Yang, Liu L; Zhao, Jie J; Zhang, Hui H; Shao, Ying Y; Sun, Hongye H; Sun, Lele L; Cai, Jiaoyang J; Sun, Hui-Ying HY; Lin, Ting-Nien TN; Du, Lijuan L; Li, Hui H; Rusch, Michael M; Edmonson, Michael N MN; Easton, John J; Zhu, Xiaofan X; Zhang, Jingliao J; Cheng, Cheng C; Raphael, Benjamin J BJ; Tang, Jingyan J; Downing, James R JR; Alexandrov, Ludmil B LB; Zhou, Bin-Bing S BS; Pui, Ching-Hon CH; Yang, Jun J JJ; Zhang, Jinghui J
Publication Date: 2020-01-02

Variant appearance in text: KRAS: F156L
PubMed Link: 31697823
Variant Present in the following documents:
  • Main text
View BVdb publication page



Finding driver mutations in cancer: Elucidating the role of background mutational processes.

Plos Computational Biology
Brown, Anna-Leigh AL; Li, Minghui M; Goncearenco, Alexander A; Panchenko, Anna R AR
Publication Date: 2019-04

Variant appearance in text: KRAS: F156L
PubMed Link: 31034466
Variant Present in the following documents:
  • pcbi.1006981.s010.xlsx, sheet 1
View BVdb publication page



From mutations to mechanisms and dysfunction via computation and mining of protein energy landscapes.

Bmc Genomics
Qiao, Wanli W; Akhter, Nasrin N; Fang, Xiaowen X; Maximova, Tatiana T; Plaku, Erion E; Shehu, Amarda A
Publication Date: 2018-09-24

Variant appearance in text: KRAS: F156L
PubMed Link: 30255791
Variant Present in the following documents:
  • 12864_2018_Article_5024.pdf
View BVdb publication page



Correlation between MEK signature and Ras gene alteration in advanced gastric cancer.

Oncotarget
Ahn, Soomin S; Brant, Roz R; Sharpe, Alan A; Dry, Jonathan R JR; Hodgson, Darren R DR; Kilgour, Elaine E; Kim, Kyung K; Kim, Seung Tae ST; Park, Se Hoon SH; Kang, Won Ki WK; Kim, Kyoung-Mee KM; Lee, Jeeyun J
Publication Date: 2017-12-08

Variant appearance in text: KRAS: F156L
PubMed Link: 29296181
Variant Present in the following documents:
  • Main text
  • oncotarget-08-107492.pdf
View BVdb publication page



RASopathies: unraveling mechanisms with animal models.

Disease Models & Mechanisms
Jindal, Granton A GA; Goyal, Yogesh Y; Burdine, Rebecca D RD; Rauen, Katherine A KA; Shvartsman, Stanislav Y SY
Publication Date: 2015-08-01

Variant appearance in text: KRAS: F156L
PubMed Link: 26203125
Variant Present in the following documents:
  • supp_8.8.769_DMM020339supp.pdf
View BVdb publication page



Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.

Molecular Systems Biology
Kiel, Christina C; Serrano, Luis L
Publication Date: 2014-05-06

Variant appearance in text: KRAS: F156L
PubMed Link: 24803665
Variant Present in the following documents:
  • Main text
  • MSB-10-5-727-s14.xlsx, sheet 1
  • MSB-10-5-727-s13.xls, sheet 1
  • MSB-10-5-727.pdf
View BVdb publication page



A lethal course of hypertrophic cardiomyopathy in Noonan syndrome due to a novel germline mutation in the KRAS gene: case study.

Croatian Medical Journal
Nosan, Gregor G; Bertok, Sara S; Vesel, Samo S; Yntema, Helger G HG; Paro-Panjan, Darja D
Publication Date: 2013-12

Variant appearance in text: KRAS: Phe156Leu
PubMed Link: 24382853
Variant Present in the following documents:
  • Main text
  • CroatMedJ_54_0574.pdf
View BVdb publication page



Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.

American Journal Of Medical Genetics. Part A
Rauen, Katherine A KA; Schoyer, Lisa L; McCormick, Frank F; Lin, Angela E AE; Allanson, Judith E JE; Stevenson, David A DA; Gripp, Karen W KW; Neri, Giovanni G; Carey, John C JC; Legius, Eric E; Tartaglia, Marco M; Schubbert, Suzanne S; Roberts, Amy E AE; Gelb, Bruce D BD; Shannon, Kevin K; Gutmann, David H DH; McMahon, Martin M; Guerra, Carmen C; Fagin, James A JA; Yu, Benjamin B; Aoki, Yoko Y; Neel, Benjamin G BG; Balmain, Allan A; Drake, Richard R RR; Nolan, Garry P GP; Zenker, Martin M; Bollag, Gideon G; Sebolt-Leopold, Judith J; Gibbs, Jackson B JB; Silva, Alcino J AJ; Patton, E Elizabeth EE; Viskochil, David H DH; Kieran, Mark W MW; Korf, Bruce R BR; Hagerman, Randi J RJ; Packer, Roger J RJ; Melese, Teri T
Publication Date: 2010-01

Variant appearance in text: KRAS: F156L
PubMed Link: 20014119
Variant Present in the following documents:
  • Main text
View BVdb publication page